Treatment for co-infection of the lung with diabetes
Overview of treatment principles
Diabetes patients are vulnerable to co-infection with their lungs due to, inter alia, body metabolic disorders and impaired immune functions. The treatment needs to be balanced with diabetes and lung infections in order to improve treatment effectiveness and patient prognosis. The general principles of treatment are the control of blood sugar, resistance to infection, support for treatment of symptoms and the prevention of complications.
II. Control of blood sugar
Insulin treatment: Insulin treatment is often the preferred option for patients with diabetes-combinant lung infections. Because of the increased sugar hormones in patients under stress, increased resistance to insulin and the risk that oral sugar can be used to control blood sugar. Short-acting, neutral or long-acting insulin may be selected, depending on the patient ‘ s blood sugar level, weight, etc., or a continuous insulin insulin insulin pump can be used to keep the blood sugar in a relatively desirable range, generally at around 7mmol/L for an empty abdominal sugar and below 10mmol/L for 2 hours after meals.
Adjustment of the sugar programme: If the patient has previously used oral sugar, adjustments may be required during lung infections. For example, in cases of co-infection with co-oxyxic, shock, etc., in patients with pulmonary amitraz should be discontinued in order to avoid lactate poisoning. For patients with mildly ill conditions and with a slight increase in blood sugar, partial oral sugar reduction can be continued with close monitoring of blood sugar, but the dose may require appropriate adjustments.
III. Treatment against infection
1. Pathogen detection: Accurate pathogen diagnosis is key to rational use of antibacterial drugs. Specimens such as sapling, blood, etc. should be collected as soon as possible for development and drug sensitivity testing. For sapling samples, care should be taken of its mass and as far as possible deep sapling should be retained to improve the accuracy of the detection. At the same time, a combination of the results of the visual examination and the clinical performance of the patient can be used to determine the possible pathogens.
Empirical anti-infection treatment: Until the results of the pathogen are known, empirical anti-infection treatment needs to be based on the patient ‘ s severity, age, underlying disease, etc. For community access to sexually transmitted pulmonary infections, common pathogens are pneumocococcus, haemophilus influenzae, etc., with the option of β-neamamine or quinone. For hospital access to sexually transmitted pulmonary infections, consideration may need to be given to e.g., e.g., e.g., e.g., e.g., e.g., e.g., e.g., e.g., e.g., e.g., e.g., ghelane, c.l., g.l., p.e., p.e., and c. c., c., c., c., p. If the patient has high-risk factors for fungi infection, such as the long-term use of broad spectrum antibiotics, sugar-coated hormones etc., it is also necessary to be alert to fungi infections and, if necessary, to use antifluent drugs.
3. Targeted anti-infection treatment: Once the pathogen results are clear, anti-bacterial drugs should be adapted in a timely manner to the results of drug-sensitive tests and targeted treatment should be implemented to improve the effectiveness of anti-infection treatment and reduce the production of drug-resistant bacteria.
IV. Support for treatment
1 coughing: coughing medicine is available for patients who have coughing and coughing. For example, ammonia bromine can facilitate dilution and ejection of sapules, mitigate cough symptoms and keep the respiratory tract open. In cases where a dry cough severely affects the patient ‘ s rest, the anticussies can be used appropriately, but in cases where the acupuncture is sticky and uncooled, over-use of the accelerants should be avoided in order to avoid scintillation that exacerbates lung infections.
Oxygen: Oxygen treatment should be provided to patients with respiratory difficulties and low-oxygen haematosis. Depending on the patient ‘ s haematological saturation, the nose tube can be selected for oxygen, mask oxygen etc. For patients suffering from severe respiratory failure, mechanical ventilation may be required.
Nutritional support: Diabetes-combinant lung infections are in high metabolism and need to be supported with nutrition. While ensuring total caloric intake, care should be taken to rationally allocate the proportion of carbohydrates, proteins and fat. The intake of proteins can be increased appropriately to facilitate the recovery of the body, while the diet can be adapted to the blood sugar situation.
V. Complication management
1. Prevention of diabetic ketone acid poisoning and high-permeability comas: closely monitored indicators of blood sugar, blood ketone, osmosis pressure, etc. of patients, timely detection and treatment of possible acute diabetes complications. If a patient suffers from nausea, vomiting, breathing high, beware of the occurrence of diabetes ketone acid poisoning, and be treated in a timely manner with rehydration, small doses of insulin vivo, etc.
2. Combating multi-organ functional impairment syndrome: lung infections can induce or exacerbate multi-organ functional impairment syndromes, especially for older persons with diabetes with multiple underlying diseases. The function of the patient ‘ s vital organs such as heart, liver and kidneys should be closely observed and appropriate protection measures should be taken in a timely manner, such as improving microcycles and maintaining hydrolytic balance.
In general, the treatment of co-infection with the lung of diabetes needs to be considered in a multi-pronged manner, with active control of blood sugar, effective resistance to infection, enhanced support for disease and management of complications, in order to improve the treatment rate of patients and reduce mortality.
